CAS 1391076-61-1

4-[[[(2R)-1-(Benzo[b]thien-3-ylcarbonyl)-2-methyl-2-azetidinyl]carbonyl][(3-chlorophenyl)methyl]amino]butanoicacid

CAS : 1391076-61-1

Formule : C₂₅H₂₅ClN₂O₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 484.9950

Ref: IN-DA01ENLD

GLPG0974

CAS : 1391076-61-1

GLPG0974

Degré de pureté : ≥98%

Masse moléculaire : 484.99g/mol

Ref: 54-BUP14309

GLPG 0974

CAS : 1391076-61-1

GLPG 0974 is an experimental pharmaceutical compound, specifically an antagonist of the free fatty acid receptor 2 (FFA2), also known as GPR43. This compound is synthesized through a process of chemical engineering aimed at selectively inhibiting GPR43's activity. The mode of action involves blocking the interaction of short-chain fatty acids with GPR43, a receptor implicated in inflammatory pathways.

Formule : C₂₅H₂₅ClN₂O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 485 g/mol

Ref: 3D-RFC07661

GLPG0974

CAS : 1391076-61-1

GLPG0974 is an antagonist of FFA2/GPR43 with IC50 of 9 nM.

Formule : C₂₅H₂₅ClN₂O₄S

Degré de pureté : 99.8%

Couleur et forme : Solid

Masse moléculaire : 484.99

Ref: TM-T15388